Avelumab

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1331 publications

Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma.

Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma.

Journal: JAMA network open

Published: April 15, 2026

Cost of care and budget impact of novel first-line treatments in patients with locally advanced or metastatic urothelial carcinoma from the Colombian healthcare system perspective.

Cost of care and budget impact of novel first-line treatments in patients with locally advanced or metastatic urothelial carcinoma from the Colombian healthcare system perspective.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: April 14, 2026

Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.

Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.

Journal: JCO global oncology

Published: April 10, 2026

Real-world comparison of avelumab maintenance versus pembrolizumab at progression after first-line platinum-based chemotherapy in metastatic urothelial cancer.

Real-world comparison of avelumab maintenance versus pembrolizumab at progression after first-line platinum-based chemotherapy in metastatic urothelial cancer.

Journal: ESMO real world data and digital oncology

Published: April 03, 2026

Body Mass Index and Nutritional Status With Immunotherapy Response in Head and Neck Cancer.

Body Mass Index and Nutritional Status With Immunotherapy Response in Head and Neck Cancer.

Journal: JAMA otolaryngology-- head & neck surgery

Published: April 02, 2026

Recent highlights and breakthroughs in immunotherapy for head and neck cancers.

Recent highlights and breakthroughs in immunotherapy for head and neck cancers.

Journal: Current opinion in oncology

Published: March 06, 2026

Re: Three versus Six Cycles of Platinum-Based Chemotherapy Followed by Avelumab Maintenance as First-Line Treatment for Advanced Urothelial Cancer: The Phase II DISCUS Trial.

Re: Three versus Six Cycles of Platinum-Based Chemotherapy Followed by Avelumab Maintenance as First-Line Treatment for Advanced Urothelial Cancer: The Phase II DISCUS Trial.

Journal: European urology

Published: February 24, 2026

Correction to "Avelumab combined with axitinib for patients with advanced thymoma B3 and thymic carcinoma".

Correction to "Avelumab combined with axitinib for patients with advanced thymoma B3 and thymic carcinoma".

Journal: Cancer

Published: February 10, 2026

Tumor microenvironment changes after treatment with avelumab and immune-stimulating agent combinations in patients with advanced solid tumors.

Tumor microenvironment changes after treatment with avelumab and immune-stimulating agent combinations in patients with advanced solid tumors.

Journal: Research square

Published: February 06, 2026

Tumor microenvironment changes after treatment with avelumab and immune- stimulating agent combinations in patients with advanced solid tumors.

Tumor microenvironment changes after treatment with avelumab and immune- stimulating agent combinations in patients with advanced solid tumors.

Journal: Research square

Published: February 06, 2026

Evolving treatment patterns and outcomes among patients with metastatic urothelial carcinoma post-avelumab maintenance approval: insights from The US Oncology Network.

Evolving treatment patterns and outcomes among patients with metastatic urothelial carcinoma post-avelumab maintenance approval: insights from The US Oncology Network.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Avelumab real-world use in advanced Merkel cell carcinoma: a systematic review and non-comparative meta-analysis.

Avelumab real-world use in advanced Merkel cell carcinoma: a systematic review and non-comparative meta-analysis.

Journal: Future oncology (London, England)

Published: January 23, 2026

Showing 1-12 of 1,331

Last Updated: 04/28/2026